Clinical Trials Browser

Phase 2 × Ganglioneuroblastoma × Etoposide × Clear all

NCT03786783 2026-06-02

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Phase 2 Completed

42 enrolled 12 charts

Ganglioneuroblastoma